Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

    Forecasted

    FDA grant seeks research to reduce nitrosamine impurities in drugs, ensuring public safety and continued access to needed medications, with a plan for sustained research.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Collaborations to Enhance Drug Development and Regulatory Science

    FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.

    HHS-FDA$5,000,000Forecasted

    Minor Use Minor Species Development of Drugs (R01)

    FDA grants support research for new animal drugs with minor uses or for minor species, requiring an INAD file, MUMS designation, and ONADE-approved study protocol.

    HHS-FDA$250,000Forecasted

    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

    NIDA plans to fund research developing interventions to prevent and treat substance use disorders and overdoses, from preclinical studies to clinical trials.

    HHS-NIH11Due Feb 22, 2027$15,000,000

    Minor Use Minor Species Development of Drugs (R01)

    FDA grants support research for new animal drugs with minor uses in major species or for minor species, requiring an INAD file, MUMS designation, and protocol review.

    HHS-FDADue Dec 25, 2026$250,000

    Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed

    FDA grant for collecting data on antimicrobial use in various animal sectors to improve stewardship and support national action plans.

    HHS-FDA$200,000Forecasted